# Geneviève Tanguay

> Geneviève Tanguay is a seed investor at Panache Ventures backing Health Care and Medical Device. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Panache Ventures](https://shizune.co/investors/profile/panache-ventures)
- Location: Montréal, Canada
- Total investments: 2
- Last investment: Aug 2021
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/genevi%C3%A8ve-tanguay-19202214

Geneviève Tanguay is a seed investor at Panache Ventures in Montréal focused on Health Care and Medical Device. Geneviève Tanguay is the Partner of Panache Ventures. Geneviève Tanguay is the Présidente-directrice générale (PDG) / Chief Executive Officer (CEO) of Anges Québec. She received her Bachelor's Degree, Business and Finance from HEC Montréal.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 50% |
| Medical Device | 1 | 50% |
| Health Diagnostics | 1 | 50% |
| Artificial Intelligence | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Pre-Seed | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Zilia | Zilia has developed a non-invasive platform technology that uses imaging, spectrometry and artificial intelligence to quantitatively measure different biomarkers in the human eye. Zilia’s initial product, Zilia Ocular, is the first retinal camera to quantify oxygen saturation, a crucial biomarker in ocular diseases such as glaucoma, DR and AMD.Zilia aims to revolutionize the prevention, diagnosis and management of these diseases by generating actionable data about the eye’s metabolic activity. | $3.2M | Seed | Aug 11, 2021 |  |
| Gray Oncology Solutions | Gray Oncology Solutions has a vision of an oncology workflow where each patient’s journey through their cancer treatment is personalized for them, and statistically optimized to provide the best possible clinical outcomes. In pursuit of this vision, we’re developing resource allocation software focused on optimizing the functional efficiency ofentire cancer centers resulting in reduced patient wait-times, higher patient throughput, reduced stress and ultimately, superior patient care. | $999.9K | Pre-Seed | Aug 05, 2021 |  |

2 of 2 investments shown.

## Co-investors
- [Campus des Technologies de la Santé/CTS Healthcare](https://shizune.co/investors/profile/campus-des-technologies-de-la-sant%C3%A9-cts-healthcare) — VC Fund, 2 deals together
- [AQC Capital](https://shizune.co/investors/profile/anges-qu%C3%A9bec-capital) — VC Fund, 1 deal together
- [Government Of Quebec](https://shizune.co/investors/profile/government-of-quebec) — VC Fund, 1 deal together
- [Investissement Quebec](https://shizune.co/investors/profile/investissement-quebec) — VC Fund, 1 deal together
- [Science Center](https://shizune.co/investors/profile/science-center) — VC Fund, 1 deal together

## About Panache Ventures

VC Fund · Montréal, Canada

Panache Ventures is a venture capital firm specializing in pre-seed and seed-stage startup investments. It seeks to invest in sectors that play to Canada’s strengths: artificial intelligence (AI), fintech, digital health, enterprise software, and blockchain.

5 contacts available at Panache Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Mike Cegelski | Founder & Managing Partner | https://shizune.co/investors/profile/mike-cegelski |
| Patrick Lor | Managing Partner | https://shizune.co/investors/profile/patrick-lor |
| Chris Neumann | Partner | https://shizune.co/investors/profile/chris-neumann |
| Francois Arbour | LP / Venture Partner | https://shizune.co/investors/profile/francois-arbour |
| Geneviève Tanguay | Partner | https://shizune.co/investors/profile/genevi%C3%A8ve-tanguay-53ea |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Geneviève Tanguay invest in?

Geneviève Tanguay invests primarily in Health Care, Medical Device and Health Diagnostics startups, most often at Seed and Pre-Seed stage. Most of the 2 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Geneviève Tanguay last invest?

The most recent investment recorded for Geneviève Tanguay closed in Aug 2021. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co